4//SEC Filing
Schoenberg Mark 4
Accession 0001437749-25-028707
CIK 0001668243other
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 6:37 PM ET
Size
8.2 KB
Accession
0001437749-25-028707
Insider Transaction Report
Form 4
Schoenberg Mark
Chief Medical Officer
Transactions
- Sale
Ordinary Shares
2025-09-08$19.11/sh−871$16,645→ 149,025 total - Exercise/Conversion
Ordinary Shares
2025-09-07+1,667→ 149,896 total - Exercise/Conversion
Restricted Stock Units
2025-09-07−1,667→ 1,667 total→ Ordinary Shares (1,667 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
- [F2]Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
- [F3]The reporting person was granted RSUs on September 7, 2023 representing 5,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024.
Documents
Issuer
UroGen Pharma Ltd.
CIK 0001668243
Entity typeother
Related Parties
1- filerCIK 0001763581
Filing Metadata
- Form type
- 4
- Filed
- Sep 8, 8:00 PM ET
- Accepted
- Sep 9, 6:37 PM ET
- Size
- 8.2 KB